Nordstrom shares tumble after retailer cuts earnings outlook

November 14, 2015 at 8:00PM

Tough sale: Department store operator Nordstrom's shares dropped 15 percent, to $53.96 Friday after the retailer reported an earnings decline and cut its guidance amid concern that store traffic is falling short of expectations.

Soft sales: Macy's shares dropped 14 percent, to $40.56 Wednesday after it reported lower than expected third-quarter sales and cut its profit forecast for the year. The retailer also said it would not form a real estate investment trust for its properties. Macy's shares finished the week at $39.10.

Bad trip: Travel site Priceline fell 10 percent Monday to $1,311.15 after the company's outlook for the fourth quarter, a typically strong period for travel companies, came up short of analysts' expectations. Airbnb's effect on hotel bookings is a key issue. Priceline shares closed the week at $1,297.75.

Shorted: Drugmaker Mallinckrodt fell 17 percent, to $58.01 Monday after the short-selling firm Citron Research warned that the company might have reimbursement problems similar to Valeant Pharmaceuticals. Mallinckrodt shares closed the week at $56.94.

Earnings: Gap plunged 5.1 percent, to $26.27 Tuesday after the company posted disappointing results for October particularly at its Banana Republic stores, which it said would affect quarterly results. Gap shares closed the week at $25.23.

Strong results: Homebuilder D.R. Horton rose 5 percent, to $30.11 after reporting a 44 percent increase in fiscal fourth-quarter profits that surpassed analyst estimates. The company also said orders were up 19 percent. D.R. Horton shares closed the week at $30.67.

news services

about the writer

about the writer

More from Business

See More
card image
Fairview Health Services

The school is changing an elective course while still working with the Eden Prairie-based health care giant after students raised concerns.

This transmission electron microscope image shows SARS-CoV-2, the virus that causes COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in the lab. (NIAID/TNS) ORG XMIT: 1659810
card image